29 research outputs found
Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays
A highly reproducible and sensitive real-time detection assay based on
TaqMan technology was developed for the detection of hepatitis B viru
Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy
A new hepatitis B virus variant selected during lamivudine treatment was detected, in which the methionine (rtM204) in the so-called YMDD motif in the C
Development of a real-time quantitative assay for detection of Epstein-Barr virus
With the use of real-time PCR, we developed and evaluated a rapid,
sensitive, specific, and reproducible method for the detection of
Epstein-Barr virus (EBV) DNA in plasma samples. This method allowed us to
screen plasma and serum samples over a range between 100 and 10(7) copies
of DNA per ml using two sample preparation methods based on absorption. A
precision study yielded an average coefficient of variation for both
methods of less than 12%, with a coefficient of regression for the
standard curve of a minimum of 0. 98. We detected EBV DNA in 19.2% of
plasma samples from immunosuppressed solid-organ transplant patients
without symptoms of EBV infections with a mean load of 440 copies per ml.
EBV DNA could be detected in all transplant patients diagnosed with
posttransplant lymphoproliferative disorder, with a mean load of 544,570
copies per ml. No EBV DNA could be detected in healthy individuals in
nonimmunosuppressed control groups and a mean of 6,400 copies per ml could
be detected in patients with infectious mononucleosis. Further studies
revealed that the inhibitory effect of heparinized plasma could be
efficiently removed by use of an extraction method with Celite as the
absorbent
Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis
Abstract Introduction To determine whether IL4R single-nucleotide polymorphisms (SNPs) rs1805010 (I50V) and rs1801275 (Q551R), which have been associated with disease severity in rheumatoid arthritis (RA) patients of European ancestry, relate to the presence of rheumatoid nodules and radiographic erosions in African Americans. Methods Two IL4R SNPs, rs1805010 and rs1801275, were genotyped in 749 patients from the Consortium for Longitudinal Evaluation of African-Americans with Early Rheumatoid Arthritis (CLEAR) registries. End points were rheumatoid nodules defined as present either by physical examination or by chest radiography and radiographic erosions (radiographs of hands/wrists and feet were scored using the modified Sharp/van der Heijde system). Statistical analyses were performed by using logistic regression modeling adjusted for confounding factors. Results Of the 749 patients with RA, 156 (20.8%) had rheumatoid nodules, with a mean age of 47.0 years, 84.6% female gender, and median disease duration of 1.9 years. Of the 461 patients with available radiographic data, 185 (40.1%) had erosions (score >0); their mean age was 46.7 years; 83.3% were women; and median disease duration was 1.5 years. Patients positive for HLA-DRB1 shared epitope (SE) and autoantibodies (rheumatoid factor (RF) or anti-cyclic citrullinated peptide (CCP)) had a higher risk of developing rheumatoid nodules in the presence of the AA and AG alleles of rs1801275 (odds ratio (OR)adj = 8.08 (95% confidence interval (CI): 1.60-40.89), P = 0.01 and ORadj = 2.97 (95% CI, 1.08 to 8.17), P = 0.04, respectively). Likewise, patients positive for the HLA-DRB1 SE and RF alone had a higher risk of developing rheumatoid nodules in presence of the AA and AG alleles of rs1801275 (ORadj = 8.45 (95% CI, 1.57 to 45.44), P = 0.01, and ORadj = 3.57 (95% CI, 1.18 to 10.76), P = 0.02, respectively) and in the presence of AA allele of rs1805010 (ORadj = 4.52 (95% CI, 1.20 to 17.03), P = 0.03). No significant association was found between IL4R and radiographic erosions or disease susceptibility, although our statistical power was limited by relatively small numbers of cases and controls. Conclusions We found that IL4R SNPs, rs1801275 and rs1805010, are associated with rheumatoid nodules in autoantibody-positive African-American RA patients with at least one HLA-DRB1 allele encoding the SE. These findings highlight the need for analysis of genetic factors associated with clinical RA phenotypes in different racial/ethnic populations
"Barter and Non-Monetary Transactions in Transition Economies: Evidence from a Cross-Country Survey"
Competition and enterprise performance in transition ecomomies: Evidence from a cross-country Survey
Development of a real-time quantitative assay for detection of Epstein-Barr virus
With the use of real-time PCR, we developed and evaluated a rapid,
sensitive, specific, and reproducible method for the detection of
Epstein-Barr virus (EBV) DNA in plasma samples. This method allowed us to
screen plasma and serum samples over a range between 100 and 10(7) copies
of DNA per ml using two sample preparation methods based on absorption. A
precision study yielded an average coefficient of variation for both
methods of less than 12%, with a coefficient of regression for the
standard curve of a minimum of 0. 98. We detected EBV DNA in 19.2% of
plasma samples from immunosuppressed solid-organ transplant patients
without symptoms of EBV infections with a mean load of 440 copies per ml.
EBV DNA could be detected in all transplant patients diagnosed with
posttransplant lymphoproliferative disorder, with a mean load of 544,570
copies per ml. No EBV DNA could be detected in healthy individuals in
nonimmunosuppressed control groups and a mean of 6,400 copies per ml could
be detected in patients with infectious mononucleosis. Further studies
revealed that the inhibitory effect of heparinized plasma could be
efficiently removed by use of an extraction method with Celite as the
absorbent
Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays
A highly reproducible and sensitive real-time detection assay based on TaqMan technology was developed for the detection of hepatitis B virus (HBV) DNA and compared with two commercially available assays. The assay was validated with the Viral Quality Control panel, which also includes EUROHEP HBV DNA standards. This real-time PCR detection system had a dynamic range of 373 to 10(10) genome copies per ml and showed an excellent correlation with both the commercial HBV Digene Hybrid Capture II microplate assay (Digene Diagnostics) and the HBV MONITOR assay (Roche Diagnostics). To demonstrate its clinical utility, four chronically HBV-infected patients treated with lamuvidine were monitored using the three different assays. From the results we concluded that this assay is an excellent alternative for monitoring of HBV-infected patients in routine diagnostics and clinical practice, enabling the analysis of a large dynamic range of HBV DNA in a single, undiluted sample
A Multicenter Study Evaluation of the Digene Hybrid Capture II Signal Amplification Technique for Detection of Hepatitis B Virus DNA in Serum Samples and Testing of EUROHEP Standards
We have evaluated the new Digene Hybrid Capture II HBV DNA Test (HCII HBV), which is a 96-well microtiter plate-based signal amplification assay. This test uses hybrid capture technology that specifically detects RNA-DNA hybrids. HCII HBV is able to quantify hepatitis B virus (HBV) DNA at between 1.4 × 10(5) and 1.7 × 10(9) HBV copies per ml in a standard format. By using a modified sample preparation method, which allows the input of 30-fold more serum for an ultrasensitive format, the sensitivity of the assay can be increased reproducibly to approximately 8,000 copies of HBV per ml. By using a combination of these two formats, the assay can quantify over a total range of 6 logs. In our multicenter evaluation study, the mean laboratory-to-laboratory coefficients of variation were 22, 7, and 12% at the three sites, respectively, with a combined specificity of 98.4%. The linearities of both the standard test and the ultrasensitive test were excellent, with Spearman correlation coefficients of 0.997 and 0.999, respectively. Furthermore, the intra-assay reproducibility for the standard assay gave coefficients of variation of from 13 to 33, 9 to 21, and 3 to 8% at the three sites, respectively. HCII HBV was shown to be genotype independent when the EUROHEP standards for genotypes A and D were used. This assay allows the accurate measurement of HBV DNA levels in serum and can be clinically used for the monitoring of responses to antiviral agents for patients chronically infected with HBV